Vincent Santucci

2.1k citations

25 papers · 1.5k indexed · h-index 17

Cellular and Molecular Neuroscience top 2%
Molecular Biology top 10%
Physiology top 10%
Pharmacology top 5%
Cognitive Neuroscience top 10%

Co-authors: Gérard Le Fur R. Steinberg Philippe Soubrié Christiane Gueudet G. Néliat Xavier Emonds‐Alt Jean-Claude Brelière Florence Oury-Donat
Topics: Receptor Mechanisms and Signaling (14 papers)Neuroscience and Neuropharmacology Research (11 papers)Neuropeptides and Animal Physiology (8 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Pharmacology
Journals: Neuroscience Journal of Pharmacology and Experimental Therapeutics Neuropsychopharmacology
Partner nations: France United States Italy

In The Last Decade

Vincent Santucci

25 papers receiving 1.4k citations

Peers

Countries citing papers authored by Vincent Santucci

Since Specialization

Citations

This map shows the geographic impact of Vincent Santucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Santucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Santucci more than expected).

Fields of papers citing papers by Vincent Santucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Santucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Santucci. The network helps show where Vincent Santucci may publish in the future.

Co-authorship network of co-authors of Vincent Santucci

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Santucci. A scholar is included among the top collaborators of Vincent Santucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Santucci. Vincent Santucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle 2016 ·Andrologia ·Vincent J. Dalbo,Michael D. Roberts,C. Brooks Mobley,Christopher G. Ballmann,Wesley C. Kephart,Carlton D. Fox,Vincent Santucci,Christine F. Conover,Luke A. Beggs,(unknown),Frederic J. Hoerr,Joshua F. Yarrow,Stephen E. Borst,Darren T. Beck	19
2	Comparative effects of whey protein versus l-leucine on skeletal muscle protein synthesis and markers of ribosome biogenesis following resistance exercise 2015 ·Amino Acids ·C. Brooks Mobley,Carlton D. Fox,Richard M. Thompson,James C. Healy,Vincent Santucci,Wesley C. Kephart,(unknown),(unknown),David D. Pascoe,Jeffrey S. Martin,Jordan R. Moon,Kaelin C. Young,Michael D. Roberts	24
3	Effects of the β3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: Relevance to its antidepressant/anxiolytic-like profile 2008 ·Neuroscience ·Y. Claustre,(unknown),Vincent Santucci,I. Bougault,Christophe Desvignes,L. Rouquier,(unknown),Peter Keane,S. Büsch,Yunjia Chen,Vaseem A. Palejwala,Michael J. Tocci,(unknown),Michel Didier,Patrick Avenet,G. Le Fur,Florence Oury-Donat,B. Scatton,R. Steinberg	49
4	Stimulation of the β3-Adrenoceptor as a Novel Treatment Strategy for Anxiety and Depressive Disorders 2007 ·Neuropsychopharmacology ·Jeanne Stemmelin,Caroline Cohen,Jean-Paul Terranova,(unknown),Philippe Pichat,Olivier Bergis,M. Decobert,Vincent Santucci,Dominique Françon,Richard Alonso,Stephen M. Stahl,Peter Keane,Patrick Avenet,B. Scatton,Gérard Le Fur,Guy Griebel	90
5	SSR180711, a Novel Selective α7 Nicotinic Receptor Partial Agonist: (II) Efficacy in Experimental Models Predictive of Activity Against Cognitive Symptoms of Schizophrenia 2006 ·Neuropsychopharmacology ·Philippe Pichat,Olivier Bergis,Jean-Paul Terranova,Alexandre Urani,Christine W. Duarte,Vincent Santucci,Christiane Gueudet,C. Voltz,R. Steinberg,Jeanne Stemmelin,Florence Oury-Donat,Patrick Avenet,Guy Griebel,B. Scatton	207
6	Effects of ageing and increased haemolysis on the levels of dolichol in rat spleen 2001 ·Experimental Gerontology ·(unknown),(unknown),Vincent Santucci,Gabriella Cavallini,A. Donati,Z. Gori,M Maccheroni,E. Bergamini	12
7	Blockade of neurokinin3 receptors antagonizes drug-induced population response and depolarization block of midbrain dopamine neurons in guinea pigs 1999 ·Synapse ·Christiane Gueudet,Vincent Santucci,P. Soubri�,(unknown)	25
8	Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: Evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade 1997 ·Synapse ·Vincent Santucci,Christiane Gueudet,(unknown),(unknown),P. Soubri�	23
9	Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis 1996 ·Life Sciences ·Vincent Santucci,(unknown),(unknown),Gérard Le Fur	137
10	The CB1 cannabinoid receptor antagonist SR 141716A affects A9 dopamine neuronal activity in the rat 1995 ·Neuroreport ·Christiane Gueudet,Vincent Santucci,Murielle Rinaldi‐Carmona,Philippe Soubrié,Gérard Le Fur	41
11	Biochemical and electrophysiological properties of SR 57746A, a new, potent 5‐HT_1Areceptor agonist 1993 ·Fundamental and Clinical Pharmacology ·André Bachy,R. Steinberg,Vincent Santucci,Marie Fournier,Marco Landi,M. Hamon,L. Manara,(unknown),Philippe Soubrié,G. Le Fur	15
12	SR 48968, a neurokinin A (NK2) receptor antagonist 1993 ·Regulatory Peptides ·Xavier Emonds‐Alt,Charles Advenier,Tiziano Croci,L. Manara,G. Néliat,Martine Poncelet,Vincenzo Proietto,Vincent Santucci,Philippe Soubrié,Didier Van Broeck,P. Vilain,Gérard Le Fur,Jean-Claude Brelière	32
13	In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist 1993 ·European Journal of Pharmacology ·Xavier Emonds‐Alt,Jean-Daniel Doutremepuich,Michel Héaulme,G. Néliat,Vincent Santucci,R. Steinberg,P. Vilain,(unknown),(unknown),Vincenzo Proietto,Didier Van Broeck,Philippe Soubrié,Gérard Le Fur,Jean-Claude Brelière	337
14	Neuropharmacological profile of a novel and selective ligand of the sigma site: SR 31742A 1993 ·Neuropharmacology ·Martine Poncelet,Vincent Santucci,Raymond Paul,Christiane Gueudet,(unknown),(unknown),R. Steinberg,Jean-Paul Terranova,J. C. Brelière,Philippe Soubrié	34
15	Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist 1993 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Martine Poncelet,M. Arnone,Michel Héaulme,(unknown),Christiane Gueudet,Vincent Santucci,(unknown),Peter Keane,D. Gully,G. Le Fur,(unknown)	23
16	The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception 1993 ·European Journal of Pharmacology ·Vincent Santucci,Christiane Gueudet,Xavier Emonds‐Alt,Jean-Claude Brelière,Philippe Soubrié,(unknown)	27
17	SR 140333, a non-peptide antagonist of substance-P (NK1) receptor 1993 ·Neuropeptides ·Xavier Emonds‐Alt,Jean-Daniel Doutremepuich,M. Jung,(unknown),Vincent Santucci,Didier Van Broeck,P. Vilain,P. Soubrié,G. Le Fur,J. C. Brelière	12
18	Cerebral-activating (EEG) properties of two inverse agonists and of an antagonist at the benzodiazepine receptor in the rat 1989 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·Vincent Santucci,(unknown),P. Worms,Peter Keane,(unknown)	14
19	EEG effects of IV infusion of pentylenetetrazol in rats: A model for screening and classifying antiepileptic compounds 1985 ·Psychopharmacology ·Vincent Santucci,(unknown),Peter Keane,Jacques Simiand,(unknown),Michel Morre,Kathleen Bizière	5
20	Quantification of slow-wave EEG induced by atropine: Effects of physostigmine, amphetamine and haloperidol 1981 ·European Journal of Pharmacology ·Vincent Santucci,A. Glatt,(unknown),Hans-Rudolf Olpe	13

About Vincent Santucci

Vincent Santucci is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Rehabilitation, having authored 25 papers that have together received 1.5k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Neuroscience and Neuropharmacology Research (11 papers) and Neuropeptides and Animal Physiology (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (989 citations), Behavioral Neuroscience (65 citations) and Pharmacology (271 citations). Vincent Santucci has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Gérard Le Fur, R. Steinberg, Philippe Soubrié, Christiane Gueudet, G. Néliat, Xavier Emonds‐Alt, Jean-Claude Brelière, Florence Oury-Donat, P. Vilain and Didier Van Broeck. Their work appears in journals such as Neuroscience, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact